ADVERTISEMENT

Peter Sonnenreich, Contributing Writer

Emma Guttman-Yassky, MD, PhD

Feature Story

Positive Results Revealed for Atopic Dermatitis Investigational Drug Etrasimod

10/10/2021

Peter Sonnenreich, Contributing Writer

Recently presented clinical trial data on investigational drug candidate etrasimod, a novel investigational therapy, shows promise for treating moderate to severe atopic dermatitis.

Recently presented clinical trial data on investigational drug candidate etrasimod, a novel investigational therapy, shows promise for treating moderate to severe atopic dermatitis.

Recently presented clinical...

10/10/2021

The Dermatologist

Vitiligo of the hands

Feature Story

Topical JAK Inhibitor Offers Promise for Two Skin Diseases

09/15/2021

Peter Sonnenreich, Contributing Writer

Mary Anne Dunkin, Contributing Writer

A number of emerging therapies involving the JAK-STAT pathway are in the pipeline for immune-mediated inflammatory diseases. One particular Janus kinase inhibitor shows potential for atopic dermatitis and vitiligo.

A number of emerging therapies involving the JAK-STAT pathway are in the pipeline for immune-mediated inflammatory diseases. One particular Janus kinase inhibitor shows potential for atopic dermatitis and vitiligo.

A number of emerging therapies...

09/15/2021

The Dermatologist

Tralokinumab: A New Potential for Atopic Dermatitis

Partner Approved

Tralokinumab: A New Potential for Atopic Dermatitis

09/11/2020

Peter Sonnenreich, Contributing Writer

New biologic therapy tralokinumab, a human monoclonal antibody targeting IL-13, is under FDA review for the treatment of atopic dermatitis.

New biologic therapy tralokinumab, a human monoclonal antibody targeting IL-13, is under FDA review for the treatment of atopic dermatitis.

New biologic therapy...

09/11/2020

The Dermatologist

Featured Webinar

Implementing ERAS Protocols Throughout Patient Peri-Op Journey: Reductions in Complications

Advertisement

Advertisement

Advertisement

Upcoming Events

October 5 ⁠–⁠ October 6

October 14 ⁠–⁠ October 16

October 16 ⁠–⁠ October 19

October 19 ⁠–⁠ October 20

October 26 ⁠–⁠ October 27

October 29 ⁠–⁠ November 2

November 1 ⁠–⁠ November 2

November 6 ⁠–⁠ November 8

NEI Congress

November 7 ⁠–⁠ November 10

November 8 ⁠–⁠ November 10

See Full Calendar

Advertisement

Advertisement